Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
Sesmilo
Gemma
G
Endocrinology Service, Institut Universitari Dexeus, Barcelona. 30064gsl@comb.cat
Webb
Susan M
SM
D000172:Acromegaly / Q000453:epidemiology* / Q000209:etiology / Q000266:history / Q000401:mortality / Q000628:therapy; D000236:Adenoma / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D015897:Comorbidity; D016371:Cranial Irradiation / Q000706:statistics & numerical data; D003625:Data Collection / Q000379:methods; D019468:Disease Management; D004359:Drug Therapy, Combination; D004363:Drug Utilization; D049673:History, 20th Century; D049674:History, 21st Century; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007016:Hypophysectomy / Q000706:statistics & numerical data; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D017481:Receptors, Somatostatin / Q000819:agonists; D012042:Registries; D012189:Retrospective Studies; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology
D010456:Peptides, Cyclic; D017481:Receptors, Somatostatin; C060347:lanreotide; D019382:Human Growth Hormone; D013004:Somatostatin; C517782:pasireotide; C406545:pegvisomant